Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Deoxycholic acid

(Synonyms: Desoxycholic acid, Deoxycholate, DCA, Cholorebic, Cholerebic, Cholanoic Acid) Copy Product Info
😃Good

Synonyms: Desoxycholic acid, Deoxycholate, DCA, Cholorebic, Cholerebic, Cholanoic Acid

Catalog No. T2965 Copy Product Info
Purity: 99.91%
😃Good
Deoxycholic acid (DCA) is a natural product and a TGR5 receptor agonist with cell permeability and oral activity. As a metabolite of intestinal flora, this compound is widely used in research on bile acid signal transduction, glucose and lipid metabolism, and anti-inflammatory mechanisms, and has shown therapeutic potential in diabetes and liver disease models.
Pack SizePriceUSA StockGlobal StockQuantity
50 mg$30In StockIn Stock
100 mg$40In StockIn Stock
500 mg$56In StockIn Stock
1 g$68In StockIn Stock
1 mL x 10 mM (in DMSO)$44In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.91%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Deoxycholic acid (DCA) is a natural product and a TGR5 receptor agonist with cell permeability and oral activity. As a metabolite of intestinal flora, this compound is widely used in research on bile acid signal transduction, glucose and lipid metabolism, and anti-inflammatory mechanisms, and has shown therapeutic potential in diabetes and liver disease models.
Targets & IC50
CSNK1E:7.22 μM (EC50), Nicastrin:6.03 μM (EC50), FATP5:0.19 μM, NTCP:2.14 µM, FATP2:5 μM
In vitro
Methods: Primary rat hepatocytes were treated with 25–200 μM deoxycholic acid (DCA) for 24 h. miR-21 expression was detected by Real-Time RT-PCR, NF-κB activity was detected by luciferase reporter gene assay, PDCD4 was detected by Western blot, and cell apoptosis was detected by Hoechst staining and caspase-3/7 activity assay.
Results :Deoxycholic acid dose-dependently inhibited miR-21 expression, decreased NF-κB activity, and increased PDCD4 expression and cell apoptosis. [1]
Methods: C2C12 myoblasts were treated with Deoxycholic acid (50 μM) for 5 days to induce differentiation. Myosin heavy chain (MYH) was detected by immunofluorescence, and gene expression of myogenic differentiation and energy metabolism markers was detected by RT-qPCR.
Results: Deoxycholic acid significantly increased myotube differentiation index and fusion capacity, upregulated Myh1/2, Pgc-1α and other gene expression; these effects were blocked by TGR5 antagonist SBI-115. [2]
In vivo
Methods: Primary rat hepatocytes were treated with 100 μM Deoxycholic acid (DCA) for 16 or 24 hours; relevant parameters were detected by Real-Time RT-PCR, immunoblotting, and H₂DCFDA fluorescence assay.
Results: Short-term DCA treatment led to downregulation of miR-21 expression, accompanied by PIDD processing and caspase-2 activation, thereby promoting liver injury. [1]
SynonymsDesoxycholic acid, Deoxycholate, DCA, Cholorebic, Cholerebic, Cholanoic Acid
Cell Research
Primary rat hepatocytes were isolated from male rats (100 to 150 g) by collagenase perfusion. After isolation, hepatocytes were resuspended in complete Williams E medium and plated on BD Primaria™ culture dishes at 5 × 104 cells/cm2. Cells are kept at 37 °C in a humidified atmosphere of 5% CO2 for 4-6 h to allow attachment. Plates are then washed with phosphate buffered saline (PBS) 1× in order to remove dead cells and incubated in Williams E medium supplemented with 25 to 200 μM DCA or no addition (control) for 24 h. Primary rat hepatocytes are processed for total RNA and protein isolation, cell viability, cytotoxicity and caspase activity assays and Hoechst staining. (Only for Reference)
Chemical Properties
Molecular Weight392.57
FormulaC24H40O4
Cas No.83-44-3
SmilesC[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@](CC3)(C[C@H](O)CC4)[H])(C[C@@H]1O)[H])[H])(CC[C@@]2([C@@H](CCC(O)=O)C)[H])[H]
Relative Density.1.128 g/cm3
Storage & Solubility Information
StorageKeep away from direct sunlight,Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 145 mg/mL (369.36 mM), Sonication is recommended.
Ethanol: 56 mg/mL (142.65 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.5473 mL12.7366 mL25.4732 mL127.3658 mL
5 mM0.5095 mL2.5473 mL5.0946 mL25.4732 mL
10 mM0.2547 mL1.2737 mL2.5473 mL12.7366 mL
20 mM0.1274 mL0.6368 mL1.2737 mL6.3683 mL
50 mM0.0509 mL0.2547 mL0.5095 mL2.5473 mL
100 mM0.0255 mL0.1274 mL0.2547 mL1.2737 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Keywords

Related Tags: Deoxycholic acid chemical structure | Deoxycholic acid in vivo | Deoxycholic acid in vitro | Deoxycholic acid formula | Deoxycholic acid molecular weight